SCI Pharmtech Inc., - Los Angeles Times Taiwan Special Report 2025

English 正體中文

Mercuries

About SCI
Products List
R&D and PD
Quality Policy
Investors
Sustainable Development
- Corporate Governance
- ESG Report
News
Contact Us

About SCI
Products List
R&D and PD
Quality Policy
Investors
Sustainable Development
- Corporate Governance
- ESG Report
News
Contact Us

關閉

Los Angeles Times Taiwan Special Report 2025

HOME / News / Los Angeles Times Taiwan Special Report 2025

Apr 21 2025

Top-Quality, Cost-Effective and Innovative Pharmaceutical Products from Taiwan to the World

About SCI

Philosophy & History
Basic Information
Organization & team
Business Overview

Products

Active Pharmaceutical Ingredients
Intermediates
Custom Manufacturing

R&D and PD

Research & Development
Project Management
Technical team
Lab. Facilities
Pilot plant equipment
GMP equipment

Quality Policy

Quality Control
Drug Master File
Inspection

Investors

Financial Statements
Monthly Revenue
Material Information
Shareholders' Meeting
Board of Director

Sustainable Development

Corporate Governance
利害關係人專區

Contact Us

Google Map

Designed by GTUT
Site Map
Privacy Policy
COPYRIGHT (C) 2020 SCI PHARMTECH, INC. ALL RIGHTS RESERVED.